[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581431":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":24,"locations":30,"responsibleParty":48,"collaborators":10,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":73,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Children's Hospital of Soochow University","OTHER",[8,12,15,18,21],{"label":9,"type":10,"description":11,"interventionNames":10},"Mild OSA - Surgical Treatment Group",null,"Children aged 3-12 years diagnosed with mild OSA (1 \\\u003C OAHI ≤ 5 events\u002Fhour) who undergo adenotonsillectomy as the primary treatment.",{"label":13,"type":10,"description":14,"interventionNames":10},"Mild OSA - Pharmacological Group","Children aged 3-12 years diagnosed with mild OSA (1 \\\u003C OAHI ≤ 5 events\u002Fhour) who receive conservative treatment with nasal corticosteroids and leukotriene receptor antagonists.",{"label":16,"type":10,"description":17,"interventionNames":10},"Moderate OSA Group","Children aged 3-12 years diagnosed with moderate OSA (5 \\\u003C OAHI ≤ 10 events\u002Fhour) who undergo adenotonsillectomy as the primary treatment.",{"label":19,"type":10,"description":20,"interventionNames":10},"Severe OSA Group","Children aged 3-12 years diagnosed with severe OSA (OAHI \\> 10 events\u002Fhour) who undergo adenotonsillectomy as the primary treatment.",{"label":22,"type":10,"description":23,"interventionNames":10},"Healthy Control Group","Healthy children aged 3-12 years with no history of OSA or other sleep disorders. This group serves as a control for comparison.",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Tingyu Rong, Doctor","CONTACT","+8615335273857","tyrong@suda.edu.cn",[31],{"facility":5,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Suzhou","Jiangsu","215233","China","CN",{"type":39,"coordinates":40},"Point",[41,42],120.59538,31.30408,{"lat":42,"lon":41},[45],{"name":46,"role":27,"phone":47,"phoneExt":10,"email":29},"Tingyu Rong","15335273857",{"type":49,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Ying Wu","Chief Physician","100581431","observational-study-on-the-impact-of-obstructive-sleep-apnea-on-executive-function-and-empathy-development-in-children-100581431",false,"NCT06850220","Observational Study on the Impact of Obstructive Sleep Apnea on Executive Function and Empathy Development in Children","OSA-EFED","Inclusion Criteria:\n\n* Children aged 3-12 years.\n* Diagnosed with OSA due to adenoid and\u002For tonsillar hypertrophy.\n* IQ ≥ 85.\n* Parental consent for participation.\n\nExclusion Criteria:\n\n* Other primary sleep disorders (e.g., narcolepsy, restless leg syndrome).\n* Developmental delay, epilepsy, or other neurological\u002Fmetabolic disorders.\n* Chronic diseases or history of head trauma.",true,"ALL","3 Years","12 Years",{"count":64,"type":65},150,"ESTIMATED","OBSERVATIONAL","This study aims to investigate the effects of obstructive sleep apnea (OSA) on executive function and empathy development in children aged 3-12 years. The study will compare the outcomes of different treatment approaches (surgical vs. pharmacological) in children with mild OSA and track the progression of cognitive and emotional functions over 12 months. The study will also explore potential EEG biomarkers for assessing neurological damage in OSA children.",[69,70,71,72],"Pediatric Obstructive Sleep Apnea","Cognition","Empathy","EEG",[74,75,71,76,77,78,79,80],"Obstructive Sleep Apnea","Executive Function","Children","EEG Biomarkers","Cohort Study","Neurodevelopment","Adenotonsillectomy","2026-01-23",{"date":83,"type":84},"2026-01-26","ACTUAL",{"date":86,"type":84},"2025-10-13",{"date":88,"type":65},"2027-06-30",{"name":5,"class":6},1]